Effects of isometric contraction on intramuscular level of neuropeptide Y and local pain perception

Acta Odontologica Scandinavica

Volumn 64, Issue 6, 2006, Pages 360-367

  Hedenberg Magnusson, Britt ^a   Brodda Jansen, Gunilla ^b   Ernberg, Malin ^c   Kopp, Sigvard ^c  

^a Eastman Dental Institute Stockholm   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Isometric contraction; Microdialysis; Neuropeptide Y; Pain; Skeletal muscle

Indexed keywords

NEUROPEPTIDE Y;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; MASSETER MUSCLE; MICRODIALYSIS; MUSCLE ISOMETRIC CONTRACTION; MYALGIA; NOCICEPTION; NORMAL HUMAN; PAIN ASSESSMENT; STATISTICAL ANALYSIS; STUDENT T TEST; TRAPEZIUS MUSCLE; VISUAL ANALOG SCALE;

EID: 33845204078     PISSN: 00016357     EISSN: 15023850     Source Type: Journal    
DOI: 10.1080/00016350600856034     Document Type: Article

References (48)

1. Veiersted KB, Westgaard RH. Development of trapezius myalgia among female workers performing light manual work. Scand J Work Environ Health 1993;19:277-83.
2. Huang GJ, LeResche L, Critchlow CW, Martin MD, Drangsholt MT. Risk factors for diagnostic subgroups of painful temporomandibular disorders (TMD). J Dent Res 2002;81:284-8.
3. Lindman R, Hagberg M, Angqvist KA, Soderlund K, Hultman E, Thornell LE. Changes in muscle morphology in chronic trapezius myalgia. Scand J Work Environ Health 1991;17:347-55.
4. Hedenberg-Magnusson B, Ernberg M, Kopp S. Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system. A comparative study. Acta Odontol Scand 1997;55:344-9.
5. Larsson S-E, Ålund M, Cai H, Öberg P-Å. Chronic pain after soft tissue injury of the cervical spine: trapezius muscle blood flow and electromyography at static loads and fatigue. Pain 1994;57:173-80.
6. Larsson R, Öberg PA, Larsson SE. Changes of trapezius muscle blood flow and electromyography in chronic neck pain due to trapezius myalgia. Pain 1999;79:45-50.
7. Rosendal L, Larsson B, Kristiansen J, Peolsson M, Sogaard K, Kjaer M, et al. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain 2004;112:324-34.
8. Henriksson KG, Bengtsson A. Fibromyalgia - a clinical entity? Scand J Physiol Pharmacol 1991;69:672-7.
9. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain (Review). Pain 1993;54:241-89.
10. Levine JD, Coderre TJ, Basbaum AI. The peripheral nervous system and the inflammatory process. In: Dubner R, Gebhard GF, Bond MR, editors. Proceedings of the Vth World Congress on Pain. Amsterdam: Elsevier; 1988. p. 33-43.
11. Graven-Nielsen T, Mense S. The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin J Pain 2001;17:2-10.
12. Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. The level of serotonin in the superficial muscle in relation to local pain and allodynia. Life Sci 1999;65:313-25.
13. 4 in the human masseter muscle. Acta Odontol Scand 2001;59:348-55.
14. Lundberg JM, Terenius L, Hökfelt T, Martling C-R, Tatemoto K, Mutt V, et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982;116:477-80.
15. Zhang X, Meister B, Elde R, Verge VM, Hokfeldt T. Large calibre primary afferent neurons projecting to the gracile nucleus express neuropeptide Y after sciatic nerve lesions: an immunohistochemical and in situ hybridization study in rats. Eur J Neurosci 1993;5:1510-19.
16. Ma W, Bisby MA. Ultrastructural localization of increased neuropeptide immunoreactivity in the axons and cells of the gracile nucleus following chronic constriction injury of the sciatic nerve. Neuroscience 1999;93:335-48.
17. Zukowska-Grojec Z. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann NY Acad Sci 1995;771:219-33.
18. Lundberg JM, Martinsson A, Hemsen A, Theodorsson-Norheim E, Svedenhag J, Ekblom B, et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 1985;133:30-6.
19. Morris MJ, Cox HS, Lambert GW, Kaye DM, Jennings GL, Meredith IT, et al. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension 1997;29:137-43.
20. Zukowska Z, Grant DS, Lee EW. Neuropeptide Y. A novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 2003;13:86-92.
21. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 2003;111:1853-62.
22. Anderberg UM, Zhurong L, Berglund L, Nyberg F. Elevated plasma levels of neuropeptide Y in female fibromyalgia patients. Eur J Pain 1999;3:19-30.
23. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994;37:1583-92.
24. Ashina M, Bendtsen L, Jensen R, Ekman R, Olesen J. Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache. Pain 1999;83:541-7.
25. Onuoha GN, Alpar EK. Calcitonin gene-related peptide and other neuropeptides in the plasma of patients with soft tissue injury. Life Sci 1999;65:1351-8.
26. Lee EW, Grant DS, Movafagh S, Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 2003;24:99-106.
27. Grönlund B, Astrup A, Bie P, Christensen NJ. Noradrenaline release in skeletal muscle and in adipose tissue studied by microdialysis. Clin Sci 1991;80:595-8.
28. Baron R, Levine JD, Fields HL. Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain? Muscle Nerve 1999;22:678-95.
29. Wahren LK, Gordh T, Torebjork E. Effects of regional intravenous guanethidin in patients with neuralgia in the hand; a follow-up study over a decade. Pain 1995;62:379-85.
30. Mense S. Slowly conducting afferent fibres from deep tissues: neurobiological properties and central nervous actions. Prog Sens Physiol 1986;6:139-219.
31. Elam M, Olausson B, Skarphedinsson JO, Wallin BG. Does sypathetic nerve discharge affect the firing of polymodal C-fibre afferents in humans? Brain 1999;122:2237-44.
32. Bjerring P, Arent-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth 1990;64:173-7.
33. Hickner RC, Rosdahl H, Borg I, Ungerstedt U, Jorfeldt L, Henriksson J. The ethanol technique of monitoring local blood flow changes in rat skeletal muscle: implications for microdialysis. Acta Physiol Scand 1992;146:87-97.
34. Mertes PM, Beck B, Jaboin Y, Stricker A, Carteaux JP, Pinelli G, et al. Microdialysis in the estimation of interstitial myocardial neuropeptide Y release. Regul Pept 1993;49:81-90.
35. Theodorsson-Norheim E, Hemsen A, Brodin E, Lundberg JM. Radioimmunassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest 1985;45:355-65.
36. Schüldt K, Harms-Ringdahl B. Activity levels during isometric test contractions of neck and shoulder muscles. Scand J Rehab Med 1988;20:117-27.
37. Theodorsson-Norheim E, Hemsen A, Brodin E, Lundberg JM. Sample handling techniques when analyzing regulatory peptides. Life Sci 1987;41:845-8.
38. Hoffmann KD, Matthews MA. Comparison of sympathetic neurons in orofacial and upper extremity nerves: implications for causalgia. J Oral Maxillofac Surg 1990;48:720-6.
39. Buckwalter JB, Hamann JJ, Kluess HA, Clifford PS. Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y? Am J Physiol Heart Circ Physiol 2004 Jul;287(1):H144-9.
40. Eriksson PO, Thornell LE. Histochemical and morphological muscle-fibre characteristics of the human masseter, the medial pterygoid and the temporal muscles. Arch Oral Biol 1983;28:781-95.
41. Stål P. Characterization of human orofacial and masticatory muscles with respect to fibre types, myosins and capillaries. Morphological, enzyme-histochemical, immuno-histochemical and biochemical investigations. Swed Dent J Suppl 1994;98:1-55.
42. Svensson P, Arendt-Nielsen L. Effects of 5 days of repeated submaximal clenching on masticatory muscle pain and tenderness: an experimental study. J Orofac Pain 1996;10:330-8.
43. Babenko V, Graven-Nielsen T, Svensson P, Drewes AM, Jensen TS, Arendt-Nielsen L. Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain 1999;82:1-8.
44. Ernberg M, Lundeberg T, Kopp S. Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain 2000;85:31-9.
45. Svensson P, Cairns BE, Wang K, Hu JW, Graven-Nielsen T, Arendt-Nielsen L, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain 2003;101:221-7.
46. Dao TT, LeResche L. Gender differences in pain. J Orofac Pain 2000;14:169-84; discussion 184-95.
47. Ashina M, Jorgensen M, Stallknecht B, Mork H, Bendtsen L, Pedersen JF, et al. No release of interstitial glutamate in experimental human model of muscle pain. Eur J Pain 2005;9:337-43.
48. O'Connor PJ, Cook DB. Moderate-intensity muscle pain can be produced and sustained during cycle ergometry. Med Sci Sporst Exerc 2001;33:1046-51.